117 related articles for article (PubMed ID: 17880774)
1. A therapeutic approach in the treatment of infections of the upper airways: thiamphenicol glycinate acetylcysteinate in sequential treatment (systemic-inhalatory route).
Serra A; Schito GC; Nicoletti G; Fadda G
Int J Immunopathol Pharmacol; 2007; 20(3):607-17. PubMed ID: 17880774
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of N-acetyl-cysteine in combination with thiamphenicol in sequential (intramuscular/aerosol) therapy of upper respiratory tract infections even when sustained by bacterial biofilms.
Macchi A; Ardito F; Marchese A; Schito GC; Fadda G
J Chemother; 2006 Oct; 18(5):507-13. PubMed ID: 17127228
[TBL] [Abstract][Full Text] [Related]
3. Aerosol antibiotic therapy in children with chronic upper airway infections: a potential alternative to surgery.
Macchi A; Castelnuovo P
Int J Immunopathol Pharmacol; 2009; 22(2):303-10. PubMed ID: 19505384
[TBL] [Abstract][Full Text] [Related]
4. Recent clinical evidence of the efficacy and safety of thiamphenicol glycinate acetylcysteinate and thiamphenicol glycinate.
Grassi C; De Benedetto F
J Chemother; 2002 Jun; 14(3):279-84. PubMed ID: 12120883
[TBL] [Abstract][Full Text] [Related]
5. [Thiamphenicol glycinate acetylcysteinate in the treatment of acute respiratory infections with mucostasis].
Mayaud C; Lentschner C; Bouchoucha S; Marsac J
Eur J Respir Dis Suppl; 1980; 111():70-3. PubMed ID: 6938412
[TBL] [Abstract][Full Text] [Related]
6. Activity of aerosol thiamphenicol glycinate acetylcysteinate in a mouse model of S. pyogenes pneumonia.
Albini E; Arena E; Belluco G; Schioppacassi G; Ungheri D
Arzneimittelforschung; 1999 Jul; 49(7):631-4. PubMed ID: 10442213
[TBL] [Abstract][Full Text] [Related]
7. Comparative effect of thiamphenicol glycinate, thiamphenicol glycinate N-acetylcysteinate, amoxicillin plus clavulanic acid, ceftriaxone and clarithromycin on pulmonary clearance of Haemophilus influenzae in an animal model.
Drago L; Fassina MC; Mombelli B; De Vecchi E; Lombardi A; Gismondo MR
Chemotherapy; 2000; 46(4):275-81. PubMed ID: 10859433
[TBL] [Abstract][Full Text] [Related]
8. [Controlled trials on the use of thiamphenicol glycinate and acetylcysteine. Mucoelastographic tests and clinico-therapeutic trials].
Morandini GC; Damonte G; Finiguerra M; Caruso R
G Ital Chemioter; 1975; 22(1-2):99-104. PubMed ID: 1235361
[No Abstract] [Full Text] [Related]
9. In vitro antibacterial activity of thiamphenicol glycinate acetylcysteinate against respiratory pathogens.
Albini E; Belluco G; Berton M; Schioppacassi G; Ungheri D
Arzneimittelforschung; 1999 Jun; 49(6):533-7. PubMed ID: 10417871
[TBL] [Abstract][Full Text] [Related]
10. Comparative in vitro activity of thiamphenicol-glycinate and thiamphenicol-glycinate-acetylcysteinate and other antimicrobials against respiratory pathogens.
Drago L; De Vecchi E; Fassina MC; Mombelli B; Tocalli L; Gismondo MR
Arzneimittelforschung; 2001; 51(4):315-24. PubMed ID: 11367873
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial activity of thiamphenicol-glycinate-acetylcysteinate and other drugs against Chlamydia pneumoniae.
Lombardi A; Drago L; De Vecchi E; Mombelli B; Gismondo MR
Arzneimittelforschung; 2001; 51(3):264-7. PubMed ID: 11304944
[TBL] [Abstract][Full Text] [Related]
12. Aerosol therapy with thiamphenicol glycinate: a retrospective study on efficacy and safety in a group of sixty-six oncological patients.
Macchi A; Terranova P; Macchi S; Roselli R; Castelnuovo P
Int J Immunopathol Pharmacol; 2011; 24(1):189-93. PubMed ID: 21496402
[TBL] [Abstract][Full Text] [Related]
13. An open, comparative pilot study of thiamphenicol glycinate hydrochloride vs clarithromycin in the treatment of acute lower respiratory tract infections due to Chlamydia pneumoniae.
Todisco T; Eslami A; Baglioni S; Todisco C
J Chemother; 2002 Jun; 14(3):265-71. PubMed ID: 12120881
[TBL] [Abstract][Full Text] [Related]
14. [Observations on antibacterial activity of thiamphenicol glycinate acetylcysteinate (author's transl)].
Marca G; Albini E
Quad Sclavo Diagn; 1979 Jun; 15 Suppl 1():777-84. PubMed ID: 122158
[TBL] [Abstract][Full Text] [Related]
15. Serum and lung levels of thiamphenicol after administration of its glycinate N-acetylcysteinate ester in experimentally infected guinea pigs.
Drago L; De Vecchi E; Fassina MC; Mombelli B; Gismondo MR
Int J Antimicrob Agents; 2000 Feb; 13(4):301-3. PubMed ID: 10755245
[TBL] [Abstract][Full Text] [Related]
16. [Clinical assessment of Fluimucil in the treatment of respiratory tract infections].
Droszcz W; Gietko G; MadaliĆska M
Pneumonol Pol; 1976; 44(4):339-42. PubMed ID: 1264825
[No Abstract] [Full Text] [Related]
17. Efficacy and safety of a new 450 mg/ml florfenicol formulation administered intramuscularly in the treatment of bacterial bovine respiratory disease.
Thiry J; Rubion S; Sarasola P; Bonnier M; Hartmann M; de Haas V
Vet Rec; 2011 Nov; 169(20):526. PubMed ID: 21921060
[TBL] [Abstract][Full Text] [Related]
18. Influence of thiamphenicol on the primary functions of human polymorphonuclear leucocytes against Streptococcus pyogenes.
Tullio V; Cuffini A; Mandras N; Roana J; Banche G; Ungheri D; Carlone N
Int J Antimicrob Agents; 2004 Oct; 24(4):381-5. PubMed ID: 15380265
[TBL] [Abstract][Full Text] [Related]
19. [Role of thiamphenicol in the treatment of community-acquired lung infections].
Raymond J; Boutros N; Bergeret M
Med Trop (Mars); 2004; 64(1):33-8. PubMed ID: 15224555
[TBL] [Abstract][Full Text] [Related]
20. Inhaled hyaluronic acid as ancillary treatment in children with bacterial acute rhinopharyngitis.
Varricchio A; Capasso M; Avvisati F; Varricchio AM; De Lucia A; Brunese FP; Ciprandi G
J Biol Regul Homeost Agents; 2014; 28(3):537-43. PubMed ID: 25316142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]